Chemistry:Milademetan
From HandWiki
Milademetan is an investigational new drug that is being evaluated to treat liposarcoma.[1] It is a MDM2 inhibitor.[2]
References
- ↑ "Milademetan - Rain Oncology". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800038279.
- ↑ "Milademetan is a highly potent MDM2 inhibitor in Merkel cell carcinoma". JCI Insight 7 (13). July 2022. doi:10.1172/jci.insight.160513. PMID 35801592.
 |  |
